A coronavirus vaccine developed by Australian researchers has generated an immune response to the disease and been proven safe for use in the first round of human trials. The vaccine known as 'Covax-19' was developed by professor Nikolai Petrovsky from Flinders University in Adelaide and cleared the phase one trial this month. The vaccine known as 'Covax-19' cleared the phase one trial this month after it developed an immune response to coronavirus in human subjects. The vaccine developed by professor Nikolai Petrovsky from Flinders University reported no significant side-effects in any of the 40 volunteers who received it. The University of Queensland is also working on a coronavirus vaccine but testing is still in phase one.

Source: Daily Mail July 31, 2020 00:45 UTC